136 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Rank Status Study
21 Recruiting Endoscopic Biliary RFA of Malignant Bile Duct Obstruction
Conditions: Cholangiocarcinoma;   Bile Duct Obstruction
Interventions: Procedure: SEMS alone;   Procedure: SEMS plus radiofrequency ablation
22 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
23 Not yet recruiting Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: S-adenosyl-L-methionine
24 Recruiting Secondary Sclerosing Cholangitis in Critically Ill Patients
Condition: Secondary Sclerosing Cholangitis
25 Recruiting Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Conditions: Cholangitis;   Bacteremia
Intervention: Procedure: Cholangioscopy
26 Recruiting Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
Condition: Total Parenteral Nutrition-induced Cholestasis
Intervention: Drug: Omegaven
27 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cirrhosis
Interventions: Drug: LJN452;   Drug: Placebo
28 Recruiting Clinical and Basic Study for Pediatric Liver Transplantation
Conditions: Biliary Atresia;   Metabolic Disorders;   Fulminant Liver Failure;   Hepatic Tumors
29 Recruiting Serum Autotaxin Levels in Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
30 Recruiting Interrogating Potential Therapeutic Targets for Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Other: No intervention
31 Recruiting Compassionate Use of Omegaven IV Fat Emulsion
Conditions: Cholestasis;   Liver Disease
Intervention: Drug: Omegaven IV
32 Not yet recruiting Comparison of Diagnostic Accuranccy Before or After Stricture Dilation in Biliary Stricture
Condition: Biliary Strictures
Intervention: Procedure: Multimodal tissue-sampling methods before and after stricture dilation
33 Not yet recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin
34 Recruiting Disease Status in Primary Sclerosing Cholangitis by Elastography
Conditions: Primary Sclerosing Cholangitis;   Elastography;   Hepatic Fibrosis;   Magnetic Resonance Imaging
Intervention: Device: MR Elastography (MRE) and FibroScan
35 Not yet recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
36 Not yet recruiting Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
Conditions: Cholestasis;   Liver Disease
Interventions: Drug: Enteral fish oil;   Drug: Ursodeoxycholic Acid;   Drug: Placebo
37 Available SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Conditions: Cholestasis;   Growth Failure
Intervention: Drug: SMOFlipid
38 Recruiting B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue;   Primary Biliary Cirrhosis
Interventions: Biological: Rituximab;   Other: Placebo
39 Recruiting Compassionate Use of Omegaven in Children
Conditions: Total Parenteral Nutrition-induced Cholestasis;   Cholestasis;   Short Bowel Syndrome;   Gastroschisis;   Intestinal Atresia;   Infant, Premature, Diseases;   Cholestasis of Parenteral Nutrition
Interventions: Drug: Omegaven;   Drug: Omegaven + Intralipid
40 Recruiting IBAT Inhibitor A4250 for Cholestatic Pruritus
Condition: Biliary Cirrhosis, Primary
Intervention: Drug: A4250

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years